课题基金 / 基金详情

Development of a novel device to improve the breast milk microbiome

Development of a novel device to improve the breast milk microbiome
开发一种改善母乳微生物组的新型装置
批准号:
10058431
负责人:
金额:
$16.45万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
BoobyBiome is passionate about **empowering parents** and improving the **health of their babies** by designing products which support the infant microbiome. A healthy gut microbiome is crucial in regulating digestive, immune and metabolic functions. The breastmilk microbiome contributes **40%** of the first beneficial gut bacteria to infants. However current rates of breastfeeding are poor and preterm babies, C-section and formula-fed infants have reduced access to breastmilk. These babies have an **increased risk** of developing microbiome-related diseases, including necrotising enterocolitis, diabetes, IBS and obesity.BoobyBiome is currently developing a breastmilk-derived microbiome supplement for infants with compromised microbiomes. Throughout R&D, it became clear that certain breastfeeding methods diminish the **viability** of positive microbial communities in breastmilk. We are consequently implementing a multi-faceted approach to improving infant gut health, by sustaining the milk-derived bacteria that these babies are lacking.With this project, BoobyBiome will develop a **method to** **protect the breast milk microbiome** so all babies may be able to benefit from the thriving bacterial communities discussed, irrespective of how they receive their milk. We will: **1)** Develop a prototype, **2)** Conduct effective iterations of prototype testing and **3)** Finish with a patented, trademarked product with manufacturing and commercialisation mapped out for the next phase.As a team of female entrepreneurs and scientists we are well positioned to meet these deliverables. Key to milestone completion is our close association with the **academic community** and our **experienced advisory team**, including Dr. Bajaj-Elliott of the UCL Institute of Child Health.Effective, affordable access to breastmilk microbial communities allows for **all babies** to develop a healthy microbiome and every parent to provide that. BoobyBiome is committed to producing a **scientifically-valid** product that is **trusted** by parents, accessible to all babies, and which has the potential to **exert real change in the healthcare sector.**
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔文晓
  • 依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    边兴博
  • 依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘亚
  • 依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
    32102747
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李婉雁
  • 依托单位: